🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsSide Effects & ManagementDay 3 on sema and I feel like death warmed over — need advice Page 2

Day 3 on sema and I feel like death warmed over — need advice

roxy_nash Sat, Aug 16, 2025 at 7:33 AM 50 replies 2,150 viewsPage 2 of 10
Dr.ObesityLA
VIP Member
3,567
19,876
Dec 2023
Los Angeles, CA
Aug 16, 2025 at 9:10 AM#6
Dr.SurgeonPGH said:
The line between titrate-through and stop is not severity, it is trajectory and what else is present.

I dislike how confidently this board tells people to push through. Incidence figures around 20 to 25% at the higher doses are class-typical, but the trials also had a discontinuation column, and "manageable with protocols" is not the same as manageable for everyone.

That is the short version; the long version is somebody else's post.

10 5zoe_NC, Dr.ObesityLA, NurseKim_ATL and 7 others
Reply Quote Save Share Report
wendy_avl
Member
245
1,123
Oct 2024
Asheville, NC
Aug 16, 2025 at 9:48 AM#7

Adding the numbers, since they settle part of this. The boring version of this is the one that works, and the boring version is: measure a baseline, change one variable, wait, measure again under the same conditions. Nobody wants that answer and it is still the answer.

9 4DoseLogDan, SleepFixSam, PurityPaulOR and 6 others
Reply Quote Save Share Report
Dr.PainCLE
Senior Member
1,234
6,234
Mar 2024
Cleveland, OH
Aug 16, 2025 at 10:26 AM#8
Dr.ObesityLA said:
I dislike how confidently this board tells people to push through.

There is a second half to this that has not been said yet. The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either. Those three things can all be true at once, and most arguments here are two people holding different parts of that.

8 3oliver_london, tane_welly, Dr.PathRoch and 5 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
jason_paloalto
Member
212
890
Nov 2024
Palo Alto, CA
Aug 16, 2025 at 11:04 AM#9

Following on from tammy_FL — and this may be the naive question:

What distinguishes the nausea you can titrate through from the nausea that means stop?

Last edited: Aug 16, 2025 at 4:04 PM
7 2andrew_nyc, Dr.EndoEP, GraceAZ_72 and 4 others
Reply Quote Save Share Report
roxy_nash
Member
178
890
Dec 2024
Nashville, TN
Aug 16, 2025 at 2:06 PM#10

Closing the loop on my own question.

Follow-up: smaller meals, less fat in the two days after dosing, and not lying down afterwards. Unglamorous, and it worked within a fortnight.

9 7kim_atl_prep, sarah_TO, wendy_avl and 6 others
Reply Quote Save Share Report

Similar Threads

Nausea incidence by dose tier — STEP and SURMOUNT meta-analysis16 replies
Constipation on GLP-1: pathophysiology and fiber protocol5 replies
Alopecia on GLP-1 — telogen effluvium differential diagnosis3 replies
Gallbladder disease risk — cholelithiasis data from clinical trials12 replies
Pancreatitis risk assessment — pooled safety analysis15 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register